Supply and Earnings Risks from Surging Crude Oil and Raw Material Prices and Procurement Difficulties
First written in FY2026. 1 of 2 entries say "Worsened", first in 2026-08-05. Latest entry: 2026-08-05.
Techno Medica moved to the "Worse" side of this theme in 2026, 5 years after the typical company in this theme (2021).
The whole theme swung hardest in 2021: 35 of 55 companies on the "Worse" side.
26 other companies' latest entry also says "Worsened".
- 2026-08-05WorsenedEarnings
「Although affected by soaring raw material costs, we continued working to ensure a stable supply of consumables and other products.」
The impact of soaring raw material costs continues, and the company describes the need for ongoing measures to ensure a stable supply of consumables and other products. - FY2026First statedAnnual report
「We use plastic materials in various products and supplies, including consumables. Soaring crude oil prices resulting from instability in the Middle East, as well as shortages of raw materials and supplies, increase procurement costs. In addition, procurement difficulties or shortages of raw materials and materials could disrupt the manufacture and supply of consumables provided to medical institutions, adversely affecting production activities and profitability. We are reviewing our procurement sources and taking other measures, but if supply constraints or price increases continue longer than expected, they could affect our business performance.」
For the first time, the company separately disclosed soaring crude oil and raw material prices, shortages of raw materials and supplies, and procurement difficulties as general procurement risks distinct from the previously disclosed unstable procurement of electrolyte analysers, citing higher costs and disruptions to the manufacture and supply of consumables. Reviewing procurement sources is identified as a response measure.